By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has entered into an exclusive collaboration with Novartis to develop tools intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the international scale.

The Austin, Texas-based firm said that it would distribute the Armored RNA Quant BCR-ABL1 RNA International Scale calibrators and software reporting tools directly or through distributors worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.